- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 221/24 - Camphidines
Patent holdings for IPC class C07D 221/24
Total number of patents in this class: 16
10-year publication summary
|
0
|
1
|
2
|
1
|
7
|
2
|
0
|
1
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alkermes, Inc. | 137 |
4 |
| Board of Regents, The University of Texas System | 6062 |
3 |
| Merck Sharp & Dohme LLC | 3732 |
3 |
| Board of Trustees of Michigan State University | 1208 |
1 |
| Nippon Soda Co., Ltd. | 882 |
1 |
| Ranbaxy Laboratories Limited | 269 |
1 |
| Southwest Jiaotong University | 188 |
1 |
| Escalier Biosciences, BV | 6 |
1 |
| Libra Therapeutics, Inc. | 10 |
1 |
| Other owners | 0 |